ATRC Annual CFF
-$32.00 K
+$7.03 M+99.55%
31 December 2023
Summary:
As of January 23, 2025, ATRC annual cash flow from financing activities is -$32.00 thousand, with the most recent change of +$7.03 million (+99.55%) on December 31, 2023. During the last 3 years, it has fallen by -$189.42 million (-100.02%). ATRC annual CFF is now -100.02% below its all-time high of $189.39 million, reached on December 31, 2020.ATRC Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATRC Quarterly CFF
-$333.00 K
-$3.19 M-111.67%
30 September 2024
Summary:
As of January 23, 2025, ATRC quarterly cash flow from financing activities is -$333.00 thousand, with the most recent change of -$3.19 million (-111.67%) on September 30, 2024. Over the past year, it has dropped by -$465.00 thousand (-352.27%). ATRC quarterly CFF is now -100.17% below its all-time high of $191.07 million, reached on June 30, 2020.ATRC Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATRC TTM CFF
-$2.98 M
-$465.00 K-18.47%
30 September 2024
Summary:
As of January 23, 2025, ATRC TTM cash flow from financing activities is -$2.98 million, with the most recent change of -$465.00 thousand (-18.47%) on September 30, 2024. Over the past year, it has dropped by -$2.57 million (-629.10%). ATRC TTM CFF is now -101.46% below its all-time high of $204.89 million, reached on June 30, 2020.ATRC TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATRC Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +99.5% | -352.3% | -629.1% |
| 3 y3 years | -100.0% | +85.3% | +19.3% |
| 5 y5 years | -100.0% | -101.6% | -120.8% |
ATRC Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +99.6% | -111.1% | +96.8% | -9218.8% | +64.5% |
| 5 y | 5-year | -100.0% | +99.6% | -100.2% | +96.9% | -101.5% | +64.5% |
| alltime | all time | -100.0% | +99.6% | -100.2% | +96.9% | -101.5% | +64.5% |
AtriCure Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$333.00 K(-111.7%) | -$2.98 M(+18.5%) |
| June 2024 | - | $2.85 M(-136.3%) | -$2.52 M(+5.9%) |
| Mar 2024 | - | -$7.86 M(-433.3%) | -$2.38 M(+7328.1%) |
| Dec 2023 | -$32.00 K(-99.5%) | $2.36 M(+1687.1%) | -$32.00 K(-92.2%) |
| Sept 2023 | - | $132.00 K(-95.6%) | -$409.00 K(-56.8%) |
| June 2023 | - | $2.99 M(-154.3%) | -$946.00 K(-54.5%) |
| Mar 2023 | - | -$5.52 M(-378.4%) | -$2.08 M(-70.5%) |
| Dec 2022 | -$7.06 M(-7.6%) | $1.98 M(-589.4%) | -$7.06 M(+8.0%) |
| Sept 2022 | - | -$405.00 K(-121.8%) | -$6.53 M(-22.1%) |
| June 2022 | - | $1.86 M(-117.7%) | -$8.39 M(+12.9%) |
| Mar 2022 | - | -$10.50 M(-518.7%) | -$7.43 M(-2.7%) |
| Dec 2021 | -$7.64 M(-104.0%) | $2.51 M(-210.9%) | -$7.64 M(+106.8%) |
| Sept 2021 | - | -$2.26 M(-180.2%) | -$3.70 M(+112.8%) |
| June 2021 | - | $2.82 M(-126.3%) | -$1.74 M(-100.9%) |
| Mar 2021 | - | -$10.71 M(-265.9%) | $186.52 M(-1.5%) |
| Dec 2020 | $189.39 M(+1217.7%) | $6.45 M(-2243.9%) | $189.39 M(+2.8%) |
| Sept 2020 | - | -$301.00 K(-100.2%) | $184.29 M(-10.1%) |
| June 2020 | - | $191.07 M(-2539.0%) | $204.89 M(+1221.1%) |
| Mar 2020 | - | -$7.83 M(-678.6%) | $15.51 M(+7.9%) |
| Dec 2019 | $14.37 M(-85.7%) | $1.35 M(-93.3%) | $14.37 M(-85.2%) |
| Sept 2019 | - | $20.29 M(+1096.5%) | $97.15 M(+27.1%) |
| June 2019 | - | $1.70 M(-118.9%) | $76.42 M(-2.2%) |
| Mar 2019 | - | -$8.97 M(-110.7%) | $78.14 M(-22.0%) |
| Dec 2018 | $100.18 M(+3529.6%) | $84.13 M(<-9900.0%) | $100.18 M(+532.5%) |
| Sept 2018 | - | -$430.00 K(-112.6%) | $15.84 M(-7.7%) |
| June 2018 | - | $3.41 M(-73.9%) | $17.15 M(+0.6%) |
| Mar 2018 | - | $13.06 M(-6350.2%) | $17.05 M(+517.6%) |
| Dec 2017 | $2.76 M(-90.0%) | -$209.00 K(-123.7%) | $2.76 M(-23.8%) |
| Sept 2017 | - | $882.00 K(-73.4%) | $3.62 M(+26.5%) |
| June 2017 | - | $3.31 M(-370.5%) | $2.87 M(-88.8%) |
| Mar 2017 | - | -$1.22 M(-287.2%) | $25.68 M(-7.3%) |
| Dec 2016 | $27.70 M(+98.4%) | $654.00 K(+427.4%) | $27.70 M(-4.4%) |
| Sept 2016 | - | $124.00 K(-99.5%) | $28.95 M(-14.8%) |
| June 2016 | - | $26.13 M(+3207.2%) | $33.97 M(+162.7%) |
| Mar 2016 | - | $790.00 K(-58.7%) | $12.93 M(-7.4%) |
| Dec 2015 | $13.96 M(-78.8%) | $1.91 M(-62.8%) | $13.96 M(-15.2%) |
| Sept 2015 | - | $5.14 M(+1.1%) | $16.46 M(+46.0%) |
| June 2015 | - | $5.09 M(+179.3%) | $11.28 M(+62.1%) |
| Mar 2015 | - | $1.82 M(-58.8%) | $6.96 M(-89.4%) |
| Dec 2014 | $65.87 M | $4.42 M(-9497.9%) | $65.87 M(+6.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2014 | - | -$47.00 K(-106.1%) | $61.73 M(+0.8%) |
| June 2014 | - | $765.00 K(-98.7%) | $61.27 M(+1.4%) |
| Mar 2014 | - | $60.74 M(>+9900.0%) | $60.43 M(+125.2%) |
| Dec 2013 | $26.83 M(+907.8%) | $278.00 K(-154.8%) | $26.83 M(+2.0%) |
| Sept 2013 | - | -$507.00 K(+533.8%) | $26.30 M(+0.1%) |
| June 2013 | - | -$80.00 K(-100.3%) | $26.28 M(-0.3%) |
| Mar 2013 | - | $27.14 M(<-9900.0%) | $26.36 M(+890.3%) |
| Dec 2012 | $2.66 M(-45.1%) | -$254.00 K(-51.4%) | $2.66 M(-20.3%) |
| Sept 2012 | - | -$523.00 K(<-9900.0%) | $3.34 M(+1.9%) |
| June 2012 | - | $1000.00(-100.0%) | $3.28 M(-17.1%) |
| Mar 2012 | - | $3.44 M(+714.7%) | $3.95 M(-18.4%) |
| Dec 2011 | $4.85 M(-435.9%) | $422.00 K(-172.1%) | $4.85 M(+12.5%) |
| Sept 2011 | - | -$585.00 K(-186.3%) | $4.31 M(-4.0%) |
| June 2011 | - | $678.10 K(-84.3%) | $4.49 M(+30.9%) |
| Mar 2011 | - | $4.33 M(-3793.0%) | $3.43 M(-337.6%) |
| Dec 2010 | -$1.44 M(+57.9%) | -$117.30 K(-71.2%) | -$1.44 M(-16.8%) |
| Sept 2010 | - | -$406.90 K(+7.2%) | -$1.73 M(-11.1%) |
| June 2010 | - | -$379.50 K(-29.6%) | -$1.95 M(-142.4%) |
| Mar 2010 | - | -$539.40 K(+31.9%) | $4.61 M(-604.0%) |
| Dec 2009 | -$914.00 K(-117.3%) | -$408.90 K(-34.5%) | -$913.90 K(+90.2%) |
| Sept 2009 | - | -$624.40 K(-110.1%) | -$480.50 K(-108.8%) |
| June 2009 | - | $6.18 M(-202.0%) | $5.45 M(-1583.0%) |
| Mar 2009 | - | -$6.06 M(<-9900.0%) | -$367.30 K(-107.0%) |
| Dec 2008 | $5.28 M(-64.9%) | $24.50 K(-99.5%) | $5.28 M(+3.7%) |
| Sept 2008 | - | $5.30 M(+1355.7%) | $5.09 M(-444.3%) |
| June 2008 | - | $364.30 K(-188.6%) | -$1.48 M(-110.1%) |
| Mar 2008 | - | -$411.40 K(+148.0%) | $14.59 M(-2.9%) |
| Dec 2007 | $15.03 M(-5517.5%) | -$165.90 K(-86.9%) | $15.03 M(-0.5%) |
| Sept 2007 | - | -$1.27 M(-107.7%) | $15.11 M(-7.5%) |
| June 2007 | - | $16.43 M(>+9900.0%) | $16.33 M(-8968.5%) |
| Mar 2007 | - | $31.30 K(-136.5%) | -$184.10 K(-33.6%) |
| Dec 2006 | -$277.40 K(-100.6%) | -$85.70 K(+82.7%) | -$277.30 K(+7.6%) |
| Sept 2006 | - | -$46.90 K(-43.4%) | -$257.70 K(-100.6%) |
| June 2006 | - | -$82.80 K(+33.8%) | $44.45 M(-0.2%) |
| Mar 2006 | - | -$61.90 K(-6.4%) | $44.55 M(-0.1%) |
| Dec 2005 | $44.61 M(>+9900.0%) | -$66.10 K(-100.1%) | $44.61 M(-0.1%) |
| Sept 2005 | - | $44.66 M(>+9900.0%) | $44.68 M(>+9900.0%) |
| June 2005 | - | $13.70 K(+179.6%) | $18.60 K(+279.6%) |
| Mar 2005 | - | $4900.00 | $4900.00 |
| Dec 2004 | $89.20 K | - | - |
FAQ
- What is AtriCure annual cash flow from financing activities?
- What is the all time high annual CFF for AtriCure?
- What is AtriCure annual CFF year-on-year change?
- What is AtriCure quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for AtriCure?
- What is AtriCure quarterly CFF year-on-year change?
- What is AtriCure TTM cash flow from financing activities?
- What is the all time high TTM CFF for AtriCure?
- What is AtriCure TTM CFF year-on-year change?
What is AtriCure annual cash flow from financing activities?
The current annual CFF of ATRC is -$32.00 K
What is the all time high annual CFF for AtriCure?
AtriCure all-time high annual cash flow from financing activities is $189.39 M
What is AtriCure annual CFF year-on-year change?
Over the past year, ATRC annual cash flow from financing activities has changed by +$7.03 M (+99.55%)
What is AtriCure quarterly cash flow from financing activities?
The current quarterly CFF of ATRC is -$333.00 K
What is the all time high quarterly CFF for AtriCure?
AtriCure all-time high quarterly cash flow from financing activities is $191.07 M
What is AtriCure quarterly CFF year-on-year change?
Over the past year, ATRC quarterly cash flow from financing activities has changed by -$465.00 K (-352.27%)
What is AtriCure TTM cash flow from financing activities?
The current TTM CFF of ATRC is -$2.98 M
What is the all time high TTM CFF for AtriCure?
AtriCure all-time high TTM cash flow from financing activities is $204.89 M
What is AtriCure TTM CFF year-on-year change?
Over the past year, ATRC TTM cash flow from financing activities has changed by -$2.57 M (-629.10%)